pharmaceutical manufacturing processes and production,pharmaceutical manufacturing processes resource library. learn more about technologies to help the pharmaceutical and biotechnology industries save time, improve processes and protect brand integrity, from raw material identification through the manufacturing process to finished and packaged product inspection. contact us..process design for pharma manufacturing,pharmaceutical manufacturing processes and process technology is at the very core of nne’s expertise. our specialized knowledge of biopharmaceutical manufacturing is focused in five areas: nne's process engineers are specialized in process technologies, finished products, medical devices, active products, utility, mechanical, applied manufacturing.
leading manufacturer and exporter
We help our customers improve their operational efficiency, reduce risks
active pharmaceutical ingredients (api) production and pharmaceuticals processing at all scales in small molecules medicines manufacturing, and throughout the manufacturing line from reaction monitoring to downstream processes such as crystallization and filter cake washing. download our application notes for more information.
secondary processing step is the second unit of the production process which mainly includes the conversion of active ingredients in pharmaceutical important medicines. therefore, we can say that this unit is the unit of final drug processing is very important to develop all the products that can be used as pharmaceuticals in health
kaolin is produced from ore-bodies with inherent and largely unalterable properties. the process plant seeks to manufacture grades of kaolin, which consumer expectations (table 1). generally an ore-body will limit the range of products that can be economically produced.
in a follow-up step, the drug substance is brought into the appropriate formulation to deliver the medicinal drug product. therefore, downstream processing is an integral part of the production process and contributes significantly to the overall productivity and product quality, as well as to processing costs.
a conventional batch process can be operated safely and more efficiently in continuous mode. a common continuous process configuration is an integrated thermal tube figure 2: integrated continuous process for intermediate and api production – thermal tube reactor and msprs in series figure 3: 2010 pharma pmi composition data (per cent)
the first step in processing kaolin clay is to slurry it in a blunger with water and a dispersing agent. degritting using screens, cyclones and hydro-classifiers is the next step. the minus 325 mesh degritted clay is fractionated using centrifugal sizers to produce the fine fractions demanded by the various markets.
kaolin is a hydrated aluminum silicate. it occurs naturally as a clay that is prepared for pharmaceutical purposes by washing with water to remove sand and other impurities.(1) history. kaolin has been used commercially and medicinally for hundreds of years.
metakaolin is manufactured by the calcination of kaolin to form an amorphous pozzolanic white mineral additive for use in cement based products. calcined kaolin is an anhydrous aluminum silicate produced by heating ultrafine natural kaolin to high temperatures in a kiln.
granulation is a process of producing granules generally. in pharmaceutical manufacturing, granulation process implies the techniques that are, used to combine powdered particles to form relatively bigger ones called granules. this process is used for commercial production of tablets.
continuous processing has been widely used in the production of commodity chemicals for decades; however, the pharmaceutical industry has been slow to adopt this production method despite the potential benefits it can bring to the manufacturing process. manufacturing pharmaceuticals is generally more complex and requires more reactions and
a process for the production of zeolite a from kaolin which comprises converting the kaolin into meta-kaolin at temperatures of between 700° and 950° c. in the presence of 0.1 to 10% by weight of alkaline earth compounds calculated as oxides, 0.1 to 10% by weight of an uncolored halide or halogen, and 0.1 to 10% by weight of an alkali metal
2.1. continuous pharmaceutical process continuous process and batch process are two types of production mode in chemical industry in a broad sense. in a batch process, the raw material is charged before the processing and the product is discharged after this period of processing. in a continuous
selection of producing organism strain screening formulation medium requirements medium optimization strain improvement (molecular biology) usp process integration 9 field trials fda approval product licence marketting sales small scale bioreactor cultures (batch, fed- batch, continuous) process control requirements scale- up (>100 litre
with both the fine and coarse kaolin particle fractions, brightness is enhanced through one or move processes including bleaching, magnetic separation, flocculation, ozonation, flotation, and oxidation, which will remove iron, titanium, organic, and other undesirable materials.
naturally occurring deposits of kaolin are processed (purified) by one of two basic processes, a dry process or a wet process the dry process involves crushing, drying, pulverizing and classifying the wet processes involve formation of a kaolin slurry followed by various separation techniques (selective flocculation, magnetic separation, delamination, flotation), dewatering and drying.
refractories: refractories are produced from natural materials, combinations of compounds and minerals, such as kaolin, which are used to build structures subjectedtohightemperatures,rangingfromsimpleto sophisticatedproducts,e.g.fromfireplacebricklinings tore-entryheatshieldsforthespaceshuttle.inindustry, theyareusedtolineboilersandfurnacesofalltypes-
processing and evaluation of locally sourced kaolin for pharmaceutical production adeluola, a.o. ; ezeobiora, e.c. ; mendie, u.e. ( 2018-08-10 ) staff publications
kaolin slurry is prepared by mechanical blunging of 35–70% kaolin-water suspension for particles disaggregation with chemical dispersant (e.g. sodium hexametaphosphate, sodium silicate, tetrasodium polyphosphate and sodium polyacrylate, 0.75%) depending on the dry kaolin, added to keep the particles flocculated and preventing their agglomeration, due to the increase of the negative
mineral information institute. when kaolin is mixed with water in the range of 20 to 35 percent, it becomes plastic (i.e., it can be molded under pressure), and the shape is retained after the pressure is removed. with larger percentages of water, the kaolin forms a slurry, or watery suspension.
special selective flocculation processes have been developed in the kaolin industry, (attia, 1982) particularly for fine particle size crude clays. these processes normally flocculate the kaolinite and leave the iron and titanium contaminants in suspension. the kaolin products have a high brightness (90% to 93%) and a low b-value or yellowness factor.
dehydroxylation. after free moisture is removed, chemically bound moisture is driven off in a process known as dehydroxylation. this produces a product known as metakaolin and typically happens between 400° – 600°c. at this point, the reaction may be stopped if metakaolin is the intended product.
paper, rubber, paint, ceramics, fibreglass, cosmetics and pharmaceuticals are just some notable examples with about 5kg of kaolin used in the manufacture of each car. according to grand view research, the kaolin market is expected to climb from $us4.76bn in 2019 to $us6.3bn by 2027 with current supply impacted by environmental constraints and the exhaustion of premium production in
a large part of the kaolin production in the u.s. was exported as paper fillers, components of ceramic bodies, extender in rubber products, and paint fillers in 2019. kaolin was mainly exported to few destinations, including china, japan, and mexico, as per the stats published by the usgs in 2020.
were produced by the denaturing and hydrolysis of various protein sources (3). hair, keratin, blood meal and feathers are hydrolyzed using acid and the amino acids are extracted.